SlideShare ist ein Scribd-Unternehmen logo
1 von 26
Validity and Reliability of
        MINI – Arabic
 in Addiction Disorders .
 Albehairy A. MD, Sadek A MD, Ghanem M. MD, Asaad T. MD,
               Sheehan D.MD, Sheehan K PhD

                          by

           Dr. Ahmed Albehairy, M.D
            Psychiatry Consultant
           Ministry of Health, Egypt
The Study Need

  & Hypothesis
Aim of The Work
Aim of The Work



 Primary:


1- to examine the concordance
between the MINI-Arabic and the
CIDI –Arabic, and between the
Substance use modules in both
MINI PLUS-Arabic & CIDI –Arabic .
Aim of The Work ( cont.)

 Secondary       :

2- To compare the administration times of
 equivalent sections of the MINI-Arabic,
 MINI PLUS-Arabic, and CIDI- Arabic .

3- To assess the concordance of
 MINI- Arabic and CIDI- Arabic comorbid
 diagnoses in patients with substance use
 disorders.
Aim of The Work ( cont.)

 Secondary       ( cont.) :

4- To assess the inter-rater and retest
 reliability of the MINI-Arabic.

5- To assess the predictive value of screen
 items from the long form of the patient –
 rated MINI-SCREEN in establishing rated
 MINI diagnoses.
SUBJECTS
   And
 METHOD
Subjects:
1- Patient Group:
 A- Inclusion criteria.
 B- Exclusion criteria.
 C- Selection of cases.

2- Control Group.
Method:

 1- Procedure.

 2- Tools applied in this work .

 3- Statistical analysis.
Procedures of the Work
                          TRANSLATION
                            TRAINING

                           PILOT STUDY

                         CLINICAL HISTORY

                        CLINICAL DIAGNOSIS

                        INFORMED CONSENT

                   DEMOGRAPHIC INFORMATION

                  MINI-SCREEN RATED BY PATIENT

   MINI ADMINISTERED                       MINI ADMINISTERED
& TIMED                                  BY 2ND RATER ON 20 PTS

             MINI PLUS MODULE ADMINISTERED & TIMED

                   CIDI ADMINISTRERED & TIMED

   MINI READMINISTERED IN 1-2 DAYS TO 20 PATIENTS FOR RETEST
                        DATA ENTRY

                       DATA CHECKING/EDITING

                           DATA ANALYSIS
                       STATISTICAL REPORT

                       FINAL THESIS WRITE UP
Tools Applied in This Work

1- Mini International Neuropsychiatric
  Interview (MINI) 5.0, The MINI SCREEN
  ( long form ) and MINI-PLUS 5.0.
  ( sheehan etal., 1997)

2- Composite International Diagnostic
  Interview (CIDI), Authorized core version
  1.0. ( WHO 1990 & Karam etal.,1993).
Statistical Analysis
-   Non parametric approach.

-   Validity and reliability of MINI & MINI
    PLUS modules ( by Kappa, PPV,
    NPV, Specificity, Sensitivity, &
    Efficiency ) .

-    Hot items analysis of MINI SCREEN
    ( by Kappa, PPV, NPV, & Efficiency ) .
RESULTS



RESULT
Demographic Data
Variable                  PATIENTS DEPENDENCE AND ABUSE           Control        X2 Chi-   Sig (P)
                                                                                 square
                          FREQ.            %              FREQ.              %
Age                                                                              4.8       >0.05
14-20 years               25           21.2%          13             21.7%
21-40 years               84           71.2%          36             60%
41-65 years               9            7.6%           11             18.3%


Sex                                                                              2.27      >0.05
Male                      113          95.8%          54             90%
Female                    5            4.2%           6              10%

Religion                                                                         0.399     >0.05
Moslem                    106          89.8%          52             86.7%
C. Orthodox               12           10.2%          8              13.3%

Marital Status                                                                   12.62     <0.05*
                                                                                           <0.05*
Never married             78           66.1%          35             58.3%
Engaged                   4            3.4%           1              1.7%
Married                   22           18.6%          23             38.3%
Separated                 3            2.5%           1              1.7%
Divorced                  10           8.5%           0              0
Widow                     1            0.8%           0              0


Occupation                                            4                          8.196     >0.05
Professional Managerial   3            2.5%           19             6.7%
Clerical                  28           23.7%          1              31.7%
Skilled                   5            4.2%           17             1.7%
Student                   40           33.9%          7              28.3%
Unemployed                25           21.2%          11             11.7%
Retrieved                 17           14.4%          1              18.3%
                          0            0                             1.7%


Education                                             7                          4.53      >0.05
Illiterate                6            5.1%           4              1.7%
1ry school                8            6.8%           8              6.7%
Preparatory               14           11.9%          4              13.3%
2ry                       15           12.7%          14             6.7%
Validity of MINI
CONCORDANC        -        +          Kappa    Sensitivity     specificity          NPV           ppv      Efficiency
E RATINGS        TN        FN
                 FP        TP



CURRENT          155       3           0.83          0.83           O.97            O.97          0.83   O.96
ALC.DEP. IN      3     17
MINI & CIDI
DSM-III
       N= 178
CURRENT          153   3               0.73          0.82    O.97            O.98          O.75          O.94
ALC.DEP. IN
MINI & CIDI
ICD-10           5     17

LIFE TIME ALC.   93    8        O.55          O.86           O.73            O.93          O.57          O.77
DEP. IN MINI &
CIDI DSM-III     30    47



LIFE TIME ALC.   89    8        O.5           O.87           O.71            O.92          O.57          O.76
DEP. IN MINI &
CIDI-ICD10       34    47



CURRENT          71    3        O.73          O.96           O.83            O.95          O.86          O.73
DRUG DEP. IN
MINI & CIDI      14    90
DSM-III
Validity of MINI
                                             ( CONT.)
CONCORDANC       -         +       Kappa      Sensitivity   specificity    NPV      ppv   Efficiency
E RATINGS        TN        FN
                 FP        TP


LIFE TIME        55    11       0.71           0.9             0.79        0.83   0.83    0.86
DRUG
DEPENDENCE       15    97
IN MINI & CIDI
ICD-10
CURRENT          167   0                0.9          1        0.98        0.94    0.83    0.99
DRUG ABUSE
IN MINI & CIDI   2     9
DSMIII

CURRENT          164   0               0.62     1            0.97          1      0.63    0.95
DRUG ABUSE
IN MINI AND      5     9
CIDI ICD-10

LIFE TIME        163    0              0.86     1            0.98          1      0.75    0.98
DRUG ABUSE
IN MINI & CIDI   4     11
DSMII

LIFE TIME        159    0          0.76         1             0.96         1      0.64    0.96
DRUG ABUSE
IN MINI AND      8     11
CIDI ICD-10
Validity of MINI
                                               ( CONT.)
CONCORDANC       -        +           Kappa       Sensitivity     specificity          NPV           ppv      Efficiency
E RATINGS        TN       FN
                 FP       TP



COMORBID         99       1               0.84          0.97           O.88            O.98          0.84   O.92
DIAG IN MINI &
CIDI DSMIII      12       65



COMORBID         101      1               0.82          0.97    O.88            O.98          O.81          O.91
DIAG IN MINI &
CIDI ICD 10      14       62



ALC & DRUG       56           5    O.87          O.95           O.91            O.91          O.95          O.94
USE IN MINI &
CLINICAL         5        112
IMPRESSION


COMORBID             99       4    O.77          O.94           O.9             O.97          O.79          O.89
DIAG IN MINI &
CLINICAL         16           59
IMPRESSION
RELIABILTY OF MINI
   Diagnoses ( n=118)   Inter- rater   Retest
                         (Kappa)       (Kappa)
MINI                       0.89          0.93
MINI PLUS ( ALCOHOL &      0.91          0.98
DRUG CURRENT)
MINI PLUS ( ALCOHOL &       0.94        0.89
DRUG LIFE TIME )
MINI PLUS ( COMORBID       0.85         0.84
PSYCHIATRIC
DISORDERS)
Time duration of diagnostic interviews
       In Minutes                  Mean       S.D     Median   Min   Max
                                  (in Min.)
             MINI                   14.65     ±2.19     14      11    22


          MINI Plus                 18.94     ±3.73     18      14    32


             CIDI                   45.08     ±6.09     42      24    65


MINI Plus Alcohol & Drug Module     12.29     ±2.2      12      9     24


  CIDI Alcohol & Drug Module        23.75     ±4.11     23.5    18    56


         MINI Control                 7       ±0.49      7      5     9


       MINI Plus Control            12.00     ±1.67     12      10    15


         CIDI Control                24.6     ±3.16     24      21    29


         MINI Retest                 14.6     ±2.57     13      11    25


       MINI Plus Retest             18.46     ±3.62     18      15    29
Over all means of concordance of MINI
     SCREEN To MINI Diagnoses

Questions of MINI SCREEN        Kappa   NPV    PPV    Efficienc
Versus MINI diagnoses                                     y
    All disorder’s questions     0.55   0.54   0.96      0.86

     Drug dependence qs          0.78   0.89   0.93     0.94

          Suicidal qs            0.68   0.71   0.95     0.88

     Major depression qs         0.7    0.73   0.9      0.86

    Antisocial personality qs    0.67   0.7    0.96     0.87

     Anxiety disorders qs        0.49   0.41   0.99     0.89

      Somatization dis qs        0.83   0.8    0.88     0.93
Hot items in MINI SCREEN of
     alcohol & drug use disorders
DIAGNOSES                  Ranked hot items related
                           symptoms
1- Alcohol use disorders   1- drink & drive .
                           2- black out .
                           3- have memory loss while drinking.
                           4-become abusive when drinking .
                           5- drink to intoxication ,feel guilty
                           about drinking.
2- Drug use disorders      1-try to cut down ,try to control drug
                           use.

                           2- have a problem because of your
                           drug.
                           Need more of drug to get high and are
                           any one object to your drug use.
Hot items in MINI SCREEN of
      Comorbid Psychiatric disorders in
        alcohol & drug use disorders
DIAGNOSES                  Ranked hot items related
                           symptoms
1- Major depression        1- depression
2- Anxiety disorders       1- unexpected anxiety.
                           2- faintness.
                           3- sweaty palm.
                           4- unsteadiness.
                           5- diarrhea.
                           6- trembling.
3-Antisocial personality   1- intimidate others.
                           2- threaten other.
                           3- bully with other
DISCUSSION &             CONCLUSION

1- MINI & precision of diagnosis in
  psychiatry.
2- Sample study.
3- MINI, MINI PLUS: ( length of interview,
  validity, and reliability).
4- MINI SCREEN .
5- Conclusion.
IMPLICATIONS
1- It is very beneficial to use MINI as a diagnostic
   screening tool for psychiatric hospital
   admission and out patient clinic evaluation.
2- MINI can be used as a first step in outcome
   symptoms and disorders tracking, preparing for
   establishing data base in substance use
   disorders and management care service in
   Arab world.
3. MINI Screen can be used in primary care
   service.
Copy (2) of validity and reliability of      mini – arabic in

Weitere ähnliche Inhalte

Andere mochten auch

1 Reliability and Validity in Physical Therapy Tests
1  Reliability and Validity in Physical Therapy Tests1  Reliability and Validity in Physical Therapy Tests
1 Reliability and Validity in Physical Therapy Testsaebrahim123
 
Validity & reliability seminar
Validity & reliability seminarValidity & reliability seminar
Validity & reliability seminarmrikara185
 
8. validity and reliability of research instruments
8. validity and reliability of research instruments8. validity and reliability of research instruments
8. validity and reliability of research instrumentsRazif Shahril
 
Validity, reliability & practicality
Validity, reliability & practicalityValidity, reliability & practicality
Validity, reliability & practicalitySamcruz5
 
Validity and reliability of questionnaires
Validity and reliability of questionnairesValidity and reliability of questionnaires
Validity and reliability of questionnairesVenkitachalam R
 
Presentation Validity & Reliability
Presentation Validity & ReliabilityPresentation Validity & Reliability
Presentation Validity & Reliabilitysongoten77
 

Andere mochten auch (8)

1 Reliability and Validity in Physical Therapy Tests
1  Reliability and Validity in Physical Therapy Tests1  Reliability and Validity in Physical Therapy Tests
1 Reliability and Validity in Physical Therapy Tests
 
Validity & reliability seminar
Validity & reliability seminarValidity & reliability seminar
Validity & reliability seminar
 
Reliability and validity
Reliability and  validityReliability and  validity
Reliability and validity
 
8. validity and reliability of research instruments
8. validity and reliability of research instruments8. validity and reliability of research instruments
8. validity and reliability of research instruments
 
Rep
RepRep
Rep
 
Validity, reliability & practicality
Validity, reliability & practicalityValidity, reliability & practicality
Validity, reliability & practicality
 
Validity and reliability of questionnaires
Validity and reliability of questionnairesValidity and reliability of questionnaires
Validity and reliability of questionnaires
 
Presentation Validity & Reliability
Presentation Validity & ReliabilityPresentation Validity & Reliability
Presentation Validity & Reliability
 

Ähnlich wie Copy (2) of validity and reliability of mini – arabic in

Dr. Jason Ross - Strategies to Improve Swine Reproduction
Dr. Jason Ross - Strategies to Improve Swine ReproductionDr. Jason Ross - Strategies to Improve Swine Reproduction
Dr. Jason Ross - Strategies to Improve Swine ReproductionJohn Blue
 
Excel/VBA model for nurse scheduling in outpatient wards
Excel/VBA model for nurse scheduling in outpatient wardsExcel/VBA model for nurse scheduling in outpatient wards
Excel/VBA model for nurse scheduling in outpatient wardsParijat Sinha
 
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...Health Informatics New Zealand
 
Continuously Improving Module Test
Continuously Improving Module TestContinuously Improving Module Test
Continuously Improving Module TestBrian Hallinan
 
Good News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of MouthGood News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of MouthBSI
 
Collaboration Between Health Departments Presentation
Collaboration Between Health Departments PresentationCollaboration Between Health Departments Presentation
Collaboration Between Health Departments PresentationCDC NPIN
 
AnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJAnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJJornal do Commercio
 
Anefac - evolução mensal da taxa de juros PF
Anefac  - evolução mensal da taxa de juros PFAnefac  - evolução mensal da taxa de juros PF
Anefac - evolução mensal da taxa de juros PFJornal do Commercio
 
IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...Alex J Mitchell
 
PHARMA Target Segmentation Grid (2 plus 2)
PHARMA Target Segmentation Grid (2 plus 2)PHARMA Target Segmentation Grid (2 plus 2)
PHARMA Target Segmentation Grid (2 plus 2)Walid Saafan
 
Cribis D&B Payment Study 2012 -abstract
Cribis D&B Payment Study 2012 -abstractCribis D&B Payment Study 2012 -abstract
Cribis D&B Payment Study 2012 -abstractCRIBIS D&B
 
Banco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell
 
IPOS10 T276 - Large Scale Validation of the Emotion Thermometers as a Screen...
IPOS10 T276  - Large Scale Validation of the Emotion Thermometers as a Screen...IPOS10 T276  - Large Scale Validation of the Emotion Thermometers as a Screen...
IPOS10 T276 - Large Scale Validation of the Emotion Thermometers as a Screen...Alex J Mitchell
 

Ähnlich wie Copy (2) of validity and reliability of mini – arabic in (20)

Dr. Jason Ross - Strategies to Improve Swine Reproduction
Dr. Jason Ross - Strategies to Improve Swine ReproductionDr. Jason Ross - Strategies to Improve Swine Reproduction
Dr. Jason Ross - Strategies to Improve Swine Reproduction
 
Excel/VBA model for nurse scheduling in outpatient wards
Excel/VBA model for nurse scheduling in outpatient wardsExcel/VBA model for nurse scheduling in outpatient wards
Excel/VBA model for nurse scheduling in outpatient wards
 
Menatel delta qs opi
Menatel delta qs opiMenatel delta qs opi
Menatel delta qs opi
 
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
 
Anu Pinkerton
Anu PinkertonAnu Pinkerton
Anu Pinkerton
 
Continuously Improving Module Test
Continuously Improving Module TestContinuously Improving Module Test
Continuously Improving Module Test
 
Good News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of MouthGood News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of Mouth
 
Collaboration Between Health Departments Presentation
Collaboration Between Health Departments PresentationCollaboration Between Health Departments Presentation
Collaboration Between Health Departments Presentation
 
Curse of the Mogul
Curse of the MogulCurse of the Mogul
Curse of the Mogul
 
AnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJAnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJ
 
Anefac - evolução mensal da taxa de juros PF
Anefac  - evolução mensal da taxa de juros PFAnefac  - evolução mensal da taxa de juros PF
Anefac - evolução mensal da taxa de juros PF
 
IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 - T178 Implementation of a Screening Programme for Cancer Related Dist...
 
PHARMA Target Segmentation Grid (2 plus 2)
PHARMA Target Segmentation Grid (2 plus 2)PHARMA Target Segmentation Grid (2 plus 2)
PHARMA Target Segmentation Grid (2 plus 2)
 
2015 Benchmarking Performance
2015 Benchmarking Performance2015 Benchmarking Performance
2015 Benchmarking Performance
 
Students Reporting Use of Selected Substances in the Last 30 Days
Students Reporting Use of Selected Substances in the Last 30 Days Students Reporting Use of Selected Substances in the Last 30 Days
Students Reporting Use of Selected Substances in the Last 30 Days
 
Cribis D&B Payment Study 2012 -abstract
Cribis D&B Payment Study 2012 -abstractCribis D&B Payment Study 2012 -abstract
Cribis D&B Payment Study 2012 -abstract
 
Electronic Medical Record Adoption Model (EMRAM)
Electronic Medical Record Adoption Model (EMRAM)Electronic Medical Record Adoption Model (EMRAM)
Electronic Medical Record Adoption Model (EMRAM)
 
Banco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell FY10 Results
Banco Sabadell FY10 Results
 
IPOS10 T276 - Large Scale Validation of the Emotion Thermometers as a Screen...
IPOS10 T276  - Large Scale Validation of the Emotion Thermometers as a Screen...IPOS10 T276  - Large Scale Validation of the Emotion Thermometers as a Screen...
IPOS10 T276 - Large Scale Validation of the Emotion Thermometers as a Screen...
 
4Q12 Presentation
4Q12 Presentation4Q12 Presentation
4Q12 Presentation
 

Mehr von احمد البحيري

Ketamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdf
Ketamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdfKetamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdf
Ketamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdfاحمد البحيري
 
تأثير جائحة كوفيد – 19 علي الصحة النفسية.pptx
تأثير جائحة كوفيد – 19 علي الصحة النفسية.pptxتأثير جائحة كوفيد – 19 علي الصحة النفسية.pptx
تأثير جائحة كوفيد – 19 علي الصحة النفسية.pptxاحمد البحيري
 
Proposal for Halfway House Facility: in Addiction Rehabilitation
Proposal for Halfway House Facility: in Addiction RehabilitationProposal for Halfway House Facility: in Addiction Rehabilitation
Proposal for Halfway House Facility: in Addiction Rehabilitationاحمد البحيري
 
الصحة النفسية لكبار السن و المتقاعدين
الصحة النفسية لكبار السن و المتقاعدينالصحة النفسية لكبار السن و المتقاعدين
الصحة النفسية لكبار السن و المتقاعديناحمد البحيري
 
Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...
Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...
Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...احمد البحيري
 
Telepsychiatry, future implications in mental health services
Telepsychiatry, future implications in mental health servicesTelepsychiatry, future implications in mental health services
Telepsychiatry, future implications in mental health servicesاحمد البحيري
 
اضطراب التوحد و الاضطرابات المصاحبة
اضطراب التوحد و الاضطرابات  المصاحبة اضطراب التوحد و الاضطرابات  المصاحبة
اضطراب التوحد و الاضطرابات المصاحبة احمد البحيري
 
اساسيات الارشاد و العلاج الاسري مع مرضي الادمان
اساسيات الارشاد و العلاج الاسري مع مرضي الادمان اساسيات الارشاد و العلاج الاسري مع مرضي الادمان
اساسيات الارشاد و العلاج الاسري مع مرضي الادمان احمد البحيري
 
مقابلات زيادة الدافعية
مقابلات زيادة الدافعيةمقابلات زيادة الدافعية
مقابلات زيادة الدافعيةاحمد البحيري
 
اساسيات العلاج الجماعي في الادمان
اساسيات العلاج الجماعي في الادماناساسيات العلاج الجماعي في الادمان
اساسيات العلاج الجماعي في الادماناحمد البحيري
 
المشاكل النفس جنسية لدي المرأة ؟
المشاكل النفس جنسية لدي المرأة ؟المشاكل النفس جنسية لدي المرأة ؟
المشاكل النفس جنسية لدي المرأة ؟احمد البحيري
 

Mehr von احمد البحيري (20)

Ketamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdf
Ketamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdfKetamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdf
Ketamine_assisted_psychotherapy_essential_concepts_and_steps_lecture.pdf
 
Ketamine Therapy in psychiatry
Ketamine Therapy in psychiatryKetamine Therapy in psychiatry
Ketamine Therapy in psychiatry
 
تأثير جائحة كوفيد – 19 علي الصحة النفسية.pptx
تأثير جائحة كوفيد – 19 علي الصحة النفسية.pptxتأثير جائحة كوفيد – 19 علي الصحة النفسية.pptx
تأثير جائحة كوفيد – 19 علي الصحة النفسية.pptx
 
Consultation and liaison psychiatry me
Consultation and liaison psychiatry meConsultation and liaison psychiatry me
Consultation and liaison psychiatry me
 
Proposal for Halfway House Facility: in Addiction Rehabilitation
Proposal for Halfway House Facility: in Addiction RehabilitationProposal for Halfway House Facility: in Addiction Rehabilitation
Proposal for Halfway House Facility: in Addiction Rehabilitation
 
الصحة النفسية لكبار السن و المتقاعدين
الصحة النفسية لكبار السن و المتقاعدينالصحة النفسية لكبار السن و المتقاعدين
الصحة النفسية لكبار السن و المتقاعدين
 
Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...
Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...
Recovery- Oriented System of Care ,Motivational Approach , in Substance Use D...
 
Telepsychiatry, future implications in mental health services
Telepsychiatry, future implications in mental health servicesTelepsychiatry, future implications in mental health services
Telepsychiatry, future implications in mental health services
 
Somatic phenomenology in depression
Somatic phenomenology in depressionSomatic phenomenology in depression
Somatic phenomenology in depression
 
اضطراب التوحد و الاضطرابات المصاحبة
اضطراب التوحد و الاضطرابات  المصاحبة اضطراب التوحد و الاضطرابات  المصاحبة
اضطراب التوحد و الاضطرابات المصاحبة
 
Clinical documentations,
Clinical documentations,Clinical documentations,
Clinical documentations,
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia.ppt489266552
Schizophrenia.ppt489266552Schizophrenia.ppt489266552
Schizophrenia.ppt489266552
 
Telepsychiatry
TelepsychiatryTelepsychiatry
Telepsychiatry
 
Glutamate and schizophrenia
Glutamate and schizophreniaGlutamate and schizophrenia
Glutamate and schizophrenia
 
اساسيات الارشاد و العلاج الاسري مع مرضي الادمان
اساسيات الارشاد و العلاج الاسري مع مرضي الادمان اساسيات الارشاد و العلاج الاسري مع مرضي الادمان
اساسيات الارشاد و العلاج الاسري مع مرضي الادمان
 
مقابلات زيادة الدافعية
مقابلات زيادة الدافعيةمقابلات زيادة الدافعية
مقابلات زيادة الدافعية
 
اساسيات العلاج الجماعي في الادمان
اساسيات العلاج الجماعي في الادماناساسيات العلاج الجماعي في الادمان
اساسيات العلاج الجماعي في الادمان
 
المشاكل النفس جنسية لدي المرأة ؟
المشاكل النفس جنسية لدي المرأة ؟المشاكل النفس جنسية لدي المرأة ؟
المشاكل النفس جنسية لدي المرأة ؟
 
ادمان الكحول
ادمان الكحولادمان الكحول
ادمان الكحول
 

Copy (2) of validity and reliability of mini – arabic in

  • 1. Validity and Reliability of MINI – Arabic in Addiction Disorders . Albehairy A. MD, Sadek A MD, Ghanem M. MD, Asaad T. MD, Sheehan D.MD, Sheehan K PhD by Dr. Ahmed Albehairy, M.D Psychiatry Consultant Ministry of Health, Egypt
  • 2. The Study Need & Hypothesis
  • 3. Aim of The Work
  • 4. Aim of The Work  Primary: 1- to examine the concordance between the MINI-Arabic and the CIDI –Arabic, and between the Substance use modules in both MINI PLUS-Arabic & CIDI –Arabic .
  • 5. Aim of The Work ( cont.)  Secondary : 2- To compare the administration times of equivalent sections of the MINI-Arabic, MINI PLUS-Arabic, and CIDI- Arabic . 3- To assess the concordance of MINI- Arabic and CIDI- Arabic comorbid diagnoses in patients with substance use disorders.
  • 6. Aim of The Work ( cont.)  Secondary ( cont.) : 4- To assess the inter-rater and retest reliability of the MINI-Arabic. 5- To assess the predictive value of screen items from the long form of the patient – rated MINI-SCREEN in establishing rated MINI diagnoses.
  • 7. SUBJECTS And METHOD
  • 8. Subjects: 1- Patient Group: A- Inclusion criteria. B- Exclusion criteria. C- Selection of cases. 2- Control Group.
  • 9. Method: 1- Procedure. 2- Tools applied in this work . 3- Statistical analysis.
  • 10. Procedures of the Work TRANSLATION TRAINING PILOT STUDY CLINICAL HISTORY CLINICAL DIAGNOSIS INFORMED CONSENT DEMOGRAPHIC INFORMATION MINI-SCREEN RATED BY PATIENT MINI ADMINISTERED MINI ADMINISTERED & TIMED BY 2ND RATER ON 20 PTS MINI PLUS MODULE ADMINISTERED & TIMED CIDI ADMINISTRERED & TIMED MINI READMINISTERED IN 1-2 DAYS TO 20 PATIENTS FOR RETEST DATA ENTRY DATA CHECKING/EDITING DATA ANALYSIS STATISTICAL REPORT FINAL THESIS WRITE UP
  • 11. Tools Applied in This Work 1- Mini International Neuropsychiatric Interview (MINI) 5.0, The MINI SCREEN ( long form ) and MINI-PLUS 5.0. ( sheehan etal., 1997) 2- Composite International Diagnostic Interview (CIDI), Authorized core version 1.0. ( WHO 1990 & Karam etal.,1993).
  • 12. Statistical Analysis - Non parametric approach. - Validity and reliability of MINI & MINI PLUS modules ( by Kappa, PPV, NPV, Specificity, Sensitivity, & Efficiency ) . - Hot items analysis of MINI SCREEN ( by Kappa, PPV, NPV, & Efficiency ) .
  • 14. Demographic Data Variable PATIENTS DEPENDENCE AND ABUSE Control X2 Chi- Sig (P) square FREQ. % FREQ. % Age 4.8 >0.05 14-20 years 25 21.2% 13 21.7% 21-40 years 84 71.2% 36 60% 41-65 years 9 7.6% 11 18.3% Sex 2.27 >0.05 Male 113 95.8% 54 90% Female 5 4.2% 6 10% Religion 0.399 >0.05 Moslem 106 89.8% 52 86.7% C. Orthodox 12 10.2% 8 13.3% Marital Status 12.62 <0.05* <0.05* Never married 78 66.1% 35 58.3% Engaged 4 3.4% 1 1.7% Married 22 18.6% 23 38.3% Separated 3 2.5% 1 1.7% Divorced 10 8.5% 0 0 Widow 1 0.8% 0 0 Occupation 4 8.196 >0.05 Professional Managerial 3 2.5% 19 6.7% Clerical 28 23.7% 1 31.7% Skilled 5 4.2% 17 1.7% Student 40 33.9% 7 28.3% Unemployed 25 21.2% 11 11.7% Retrieved 17 14.4% 1 18.3% 0 0 1.7% Education 7 4.53 >0.05 Illiterate 6 5.1% 4 1.7% 1ry school 8 6.8% 8 6.7% Preparatory 14 11.9% 4 13.3% 2ry 15 12.7% 14 6.7%
  • 15. Validity of MINI CONCORDANC - + Kappa Sensitivity specificity NPV ppv Efficiency E RATINGS TN FN FP TP CURRENT 155 3 0.83 0.83 O.97 O.97 0.83 O.96 ALC.DEP. IN 3 17 MINI & CIDI DSM-III N= 178 CURRENT 153 3 0.73 0.82 O.97 O.98 O.75 O.94 ALC.DEP. IN MINI & CIDI ICD-10 5 17 LIFE TIME ALC. 93 8 O.55 O.86 O.73 O.93 O.57 O.77 DEP. IN MINI & CIDI DSM-III 30 47 LIFE TIME ALC. 89 8 O.5 O.87 O.71 O.92 O.57 O.76 DEP. IN MINI & CIDI-ICD10 34 47 CURRENT 71 3 O.73 O.96 O.83 O.95 O.86 O.73 DRUG DEP. IN MINI & CIDI 14 90 DSM-III
  • 16. Validity of MINI ( CONT.) CONCORDANC - + Kappa Sensitivity specificity NPV ppv Efficiency E RATINGS TN FN FP TP LIFE TIME 55 11 0.71 0.9 0.79 0.83 0.83 0.86 DRUG DEPENDENCE 15 97 IN MINI & CIDI ICD-10 CURRENT 167 0 0.9 1 0.98 0.94 0.83 0.99 DRUG ABUSE IN MINI & CIDI 2 9 DSMIII CURRENT 164 0 0.62 1 0.97 1 0.63 0.95 DRUG ABUSE IN MINI AND 5 9 CIDI ICD-10 LIFE TIME 163 0 0.86 1 0.98 1 0.75 0.98 DRUG ABUSE IN MINI & CIDI 4 11 DSMII LIFE TIME 159 0 0.76 1 0.96 1 0.64 0.96 DRUG ABUSE IN MINI AND 8 11 CIDI ICD-10
  • 17. Validity of MINI ( CONT.) CONCORDANC - + Kappa Sensitivity specificity NPV ppv Efficiency E RATINGS TN FN FP TP COMORBID 99 1 0.84 0.97 O.88 O.98 0.84 O.92 DIAG IN MINI & CIDI DSMIII 12 65 COMORBID 101 1 0.82 0.97 O.88 O.98 O.81 O.91 DIAG IN MINI & CIDI ICD 10 14 62 ALC & DRUG 56 5 O.87 O.95 O.91 O.91 O.95 O.94 USE IN MINI & CLINICAL 5 112 IMPRESSION COMORBID 99 4 O.77 O.94 O.9 O.97 O.79 O.89 DIAG IN MINI & CLINICAL 16 59 IMPRESSION
  • 18. RELIABILTY OF MINI Diagnoses ( n=118) Inter- rater Retest (Kappa) (Kappa) MINI 0.89 0.93 MINI PLUS ( ALCOHOL & 0.91 0.98 DRUG CURRENT) MINI PLUS ( ALCOHOL & 0.94 0.89 DRUG LIFE TIME ) MINI PLUS ( COMORBID 0.85 0.84 PSYCHIATRIC DISORDERS)
  • 19. Time duration of diagnostic interviews In Minutes Mean S.D Median Min Max (in Min.) MINI 14.65 ±2.19 14 11 22 MINI Plus 18.94 ±3.73 18 14 32 CIDI 45.08 ±6.09 42 24 65 MINI Plus Alcohol & Drug Module 12.29 ±2.2 12 9 24 CIDI Alcohol & Drug Module 23.75 ±4.11 23.5 18 56 MINI Control 7 ±0.49 7 5 9 MINI Plus Control 12.00 ±1.67 12 10 15 CIDI Control 24.6 ±3.16 24 21 29 MINI Retest 14.6 ±2.57 13 11 25 MINI Plus Retest 18.46 ±3.62 18 15 29
  • 20. Over all means of concordance of MINI SCREEN To MINI Diagnoses Questions of MINI SCREEN Kappa NPV PPV Efficienc Versus MINI diagnoses y All disorder’s questions 0.55 0.54 0.96 0.86 Drug dependence qs 0.78 0.89 0.93 0.94 Suicidal qs 0.68 0.71 0.95 0.88 Major depression qs 0.7 0.73 0.9 0.86 Antisocial personality qs 0.67 0.7 0.96 0.87 Anxiety disorders qs 0.49 0.41 0.99 0.89 Somatization dis qs 0.83 0.8 0.88 0.93
  • 21. Hot items in MINI SCREEN of alcohol & drug use disorders DIAGNOSES Ranked hot items related symptoms 1- Alcohol use disorders 1- drink & drive . 2- black out . 3- have memory loss while drinking. 4-become abusive when drinking . 5- drink to intoxication ,feel guilty about drinking. 2- Drug use disorders 1-try to cut down ,try to control drug use. 2- have a problem because of your drug. Need more of drug to get high and are any one object to your drug use.
  • 22. Hot items in MINI SCREEN of Comorbid Psychiatric disorders in alcohol & drug use disorders DIAGNOSES Ranked hot items related symptoms 1- Major depression 1- depression 2- Anxiety disorders 1- unexpected anxiety. 2- faintness. 3- sweaty palm. 4- unsteadiness. 5- diarrhea. 6- trembling. 3-Antisocial personality 1- intimidate others. 2- threaten other. 3- bully with other
  • 23.
  • 24. DISCUSSION & CONCLUSION 1- MINI & precision of diagnosis in psychiatry. 2- Sample study. 3- MINI, MINI PLUS: ( length of interview, validity, and reliability). 4- MINI SCREEN . 5- Conclusion.
  • 25. IMPLICATIONS 1- It is very beneficial to use MINI as a diagnostic screening tool for psychiatric hospital admission and out patient clinic evaluation. 2- MINI can be used as a first step in outcome symptoms and disorders tracking, preparing for establishing data base in substance use disorders and management care service in Arab world. 3. MINI Screen can be used in primary care service.